New developments in antiretroviral drug therapy for human immunodeficiency virus infections

Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes.

ESMO open·2025

SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance.

Oncogenesis·2016

PD-L1 expression in nonclear-cell renal cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis.

Oncogene·2013

'Information is information': a public perspective on incidental findings in clinical and research genome-based testing.

Clinical genetics·2013

Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis.

Oncogene·2009

Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapy.

AIDS clinical review·2000

Pediatric human immunodeficiency virus type 1 infection: updates on prevention and management.

AIDS clinical review·2000

Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.

AIDS clinical review·1997

Cytokines and cytokine therapies in HIV infection.

AIDS clinical review·1997

Pediatric HIV disease: new developments in treatment and prevention.

AIDS clinical review·1997

The epidemiology of HIV and AIDS in the United States.

AIDS clinical review·1997

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Cancer management and research·2026

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

HemaSphere·2026

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Journal of translational medicine·2026

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Blood reviews·2026

Related Experiment Videos

New developments in antiretroviral drug therapy for human immunodeficiency virus infections

Related Concept Videos

Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes.

SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance.

PD-L1 expression in nonclear-cell renal cell carcinoma.

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis.

'Information is information': a public perspective on incidental findings in clinical and research genome-based testing.

Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis.

Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapy.

Pediatric human immunodeficiency virus type 1 infection: updates on prevention and management.

Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.

Cytokines and cytokine therapies in HIV infection.

Pediatric HIV disease: new developments in treatment and prevention.

The epidemiology of HIV and AIDS in the United States.

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Related Experiment Videos

New developments in antiretroviral drug therapy for human immunodeficiency virus infections

Related Concept Videos

Related Articles